Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The State of Our Understanding of the Pathophysiology and Optimal Treatment of Depression: Glass Half Full or Half Empty?
Charles B. Nemeroff
American Journal of Psychiatry (2020) Vol. 177, Iss. 8, pp. 671-685
Closed Access | Times Cited: 128

Showing 26-50 of 128 citing articles:

TLR4 identified as a major depressive disorder gene signature mediating effects through multiple immune cells
Jia Wei, Lei Tang, Sijian Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Serum Exosomal hsa-miR-142-5p, hsa-miR-1908-5p, and hsa-miR-450b-5p as Candidate Biomarkers for Recurrent Depressive Disorder Diagnosis and ECT Treatment Response: A Preliminary Investigation
Meng Liu, Ke Fang, Xiaorui Wang, et al.
Brain Research Bulletin (2025), pp. 111345-111345
Open Access
Nano and Microemulsions for the Treatment of Depressive and Anxiety Disorders: An Efficient Approach to Improve Solubility, Brain Bioavailability and Therapeutic Efficacy
Patrícia C. Pires, Ana Cláudia Paiva‐Santos, Francisco Veiga
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2825-2825
Open Access | Times Cited: 19
Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
Jéssica L. Antunes, Joana Amado, Francisco Veiga, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 998-998
Open Access | Times Cited: 12
Ginsenoside-Rg1 synergized with voluntary running exercise protects against glial activation and dysregulation of neuronal plasticity in depression
Wenjing Wang, Lihong Wang, Liyan Wang, et al.
Food & Function (2023) Vol. 14, Iss. 15, pp. 7222-7239
Open Access | Times Cited: 11
A neuroimaging-based precision medicine framework for depression
Yao Xiao, Fay Y. Womer, Shuai Dong, et al.
Asian Journal of Psychiatry (2023) Vol. 91, pp. 103803-103803
Open Access | Times Cited: 11
Compromised B-cell homeostasis: Unraveling the link between major depression, infection and autoimmune disorders
Yuye Yin, Yuan Liu, Longfei Du, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 565-578
Closed Access
Healthcare resource utilization and costs of using Cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder
Prakash S. Masand, Anita H. Clayton, Mousam Parikh, et al.
Journal of Medical Economics (2025) Vol. 28, Iss. 1, pp. 235-244
Open Access
Mental health in medical students during COVID-19 quarantine: a comprehensive analysis across year-classes
Thais Perissotto, Thamires Clair Rodrigues Pereira da Silva, Fabricio Petermann Choueiri Miskulin, et al.
Clinics (2021) Vol. 76, pp. e3007-e3007
Open Access | Times Cited: 26
Associations between Autoimmunity and Depression: Serum IL-6 and IL-17 Have Directly Impact on the HAMD Scores in Patients with First-Episode Depressive Disorder
Lijuan Mao, Xiajin Ren, Xin Wang, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 18
Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways
Masaki Kato, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3873-3873
Open Access | Times Cited: 17
Volume enlargement of the choroid plexus and brain ventricles in drug-naïve, first-episode major depressive disorder
Gaku Hayasaki, Enkhmurun Chibaatar, Keita Watanabe, et al.
Journal of Affective Disorders (2024) Vol. 354, pp. 719-724
Open Access | Times Cited: 3
Sex-Dependent Effects of Chronic Restraint Stress on Mood-Related Behaviours and Neurochemistry in Mice
Mauritz Frederick Herselman, Liying Lin, Shayan Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10353-10353
Open Access | Times Cited: 8
Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy
Piyush Pathak, Aseem Mehra, Sant Ram, et al.
Behavioural Brain Research (2022) Vol. 430, pp. 113931-113931
Closed Access | Times Cited: 13
Attenuated interoceptive processing in individuals with major depressive disorder and high repetitive negative thinking
Heekyeong Park, Stella M. Sánchez, Rayus Kuplicki, et al.
Journal of Psychiatric Research (2022) Vol. 156, pp. 237-244
Open Access | Times Cited: 13
Bullatine A has an antidepressant effect in chronic social defeat stress mice; Implication of microglial inflammasome
Jiarui Zhang, Shu-Yuan Yin, Zu-Qi Shen, et al.
Brain Research Bulletin (2023) Vol. 195, pp. 130-140
Open Access | Times Cited: 7
CircPTK2 may be associated with depressive-like behaviors by influencing miR-182-5p
Kunyu Wang, Yu Yang, Yiwen Wang, et al.
Behavioural Brain Research (2024) Vol. 462, pp. 114870-114870
Closed Access | Times Cited: 2
Associations between somatic symptoms and remission of major depressive disorder: A longitudinal study in China
Yingchen Jiang, Dongjian Zhu, Xinyu Huang, et al.
Journal of Psychiatric Research (2024) Vol. 172, pp. 382-390
Closed Access | Times Cited: 2
Jnk1 and downstream signalling hubs regulate anxiety-like behaviours in a zebrafish larvae phenotypic screen
Ye Hong, Christel Sourander, Benjamin Hackl, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Pharmacogenetic testing in primary care could bolster depression treatment: A value proposition
Nina Sperber, Megan C. Roberts, Sarah Gonzales, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 2
Role of mitochondria-associated membranes in the hippocampus in the pathogenesis of depression
Jiarui Zhang, Shi-Yu Shen, Zu-Qi Shen, et al.
Journal of Affective Disorders (2024) Vol. 361, pp. 637-650
Closed Access | Times Cited: 2
Phosphatidylserine: A comprehensive overview of synthesis, metabolism, and nutrition
Mudassar Hussain, Imad Khan, Muneeba Naseer Chaudhary, et al.
Chemistry and Physics of Lipids (2024) Vol. 264, pp. 105422-105422
Closed Access | Times Cited: 2
Downregulation of astroglial glutamate transporter GLT-1 in the lateral habenula is associated with depressive-like behaviors in a rat model of Parkinson's disease
Shuxuan Lyu, Yuan Guo, Li Zhang, et al.
Neuropharmacology (2021) Vol. 196, pp. 108691-108691
Closed Access | Times Cited: 16
Swimming exercise ameliorates depressive-like behavior by anti-inflammation activity, rebalancing gut Escherichia coli and Lactobacilli
Zifan Ding, Longfei Du
Brain Research (2022) Vol. 1797, pp. 148113-148113
Closed Access | Times Cited: 11
Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis
Toshiya Funatsuki, Haruhiko Ogata, Hidetoshi Tahara, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12199-12199
Open Access | Times Cited: 6

Scroll to top